HTLV-1 infection promotes excessive T cell activation and transformation into adult T cell leukemia/lymphoma.


Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
15 12 2021
Historique:
received: 12 04 2021
accepted: 27 10 2021
entrez: 15 12 2021
pubmed: 16 12 2021
medline: 7 1 2022
Statut: ppublish

Résumé

Human T cell leukemia virus type 1 (HTLV-1) mainly infects CD4+ T cells and induces chronic, persistent infection in infected individuals, with some developing adult T cell leukemia/lymphoma (ATL). HTLV-1 alters cellular differentiation, activation, and survival; however, it is unknown whether and how these changes contribute to the malignant transformation of infected cells. In this study, we used single-cell RNA-sequencing and T cell receptor-sequencing to investigate the differentiation and HTLV-1-mediated transformation of T cells. We analyzed 87,742 PBMCs from 12 infected and 3 uninfected individuals. Using multiple independent bioinformatics methods, we demonstrated the seamless transition of naive T cells into activated T cells, whereby HTLV-1-infected cells in an activated state further transformed into ATL cells, which are characterized as clonally expanded, highly activated T cells. Notably, the greater the activation state of ATL cells, the more they acquire Treg signatures. Intriguingly, the expression of HLA class II genes in HTLV-1-infected cells was uniquely induced by the viral protein Tax and further upregulated in ATL cells. Functional assays revealed that HTLV-1-infected cells upregulated HLA class II molecules and acted as tolerogenic antigen-presenting cells to induce anergy of antigen-specific T cells. In conclusion, our study revealed the in vivo mechanisms of HTLV-1-mediated transformation and immune escape at the single-cell level.

Identifiants

pubmed: 34907908
pii: 150472
doi: 10.1172/JCI150472
pmc: PMC8670839
doi:
pii:

Substances chimiques

Gene Products, tax 0
HLA Antigens 0
tax protein, Human T-lymphotrophic virus 1 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MR/S000208/1
Pays : United Kingdom

Références

Immunology. 1995 Feb;84(2):193-201
pubmed: 7750994
Clin Cancer Res. 2014 Jun 1;20(11):2851-61
pubmed: 24727323
Blood. 2000 Feb 15;95(4):1386-92
pubmed: 10666215
Eur J Immunol. 2004 Dec;34(12):3379-88
pubmed: 15517606
Nat Commun. 2020 Mar 5;11(1):1201
pubmed: 32139671
Retrovirology. 2012 May 30;9:46
pubmed: 22647666
BMC Genomics. 2018 Jun 19;19(1):477
pubmed: 29914354
Br J Haematol. 1991 Nov;79(3):428-37
pubmed: 1751370
Blood. 2006 Jan 1;107(1):265-76
pubmed: 16150940
Blood. 2001 May 15;97(10):3177-83
pubmed: 11342446
Viruses. 2016 Jun 16;8(6):
pubmed: 27322308
Nature. 2018 Aug;560(7719):494-498
pubmed: 30089906
J Exp Med. 1979 Aug 1;150(2):246-55
pubmed: 88499
Nat Immunol. 2003 Apr;4(4):337-42
pubmed: 12612581
Blood. 2014 Jun 19;123(25):3925-31
pubmed: 24735963
Science. 2003 Feb 14;299(5609):1057-61
pubmed: 12522256
PLoS Pathog. 2011 Feb 10;7(2):e1001274
pubmed: 21347344
Front Immunol. 2018 Jul 10;9:1444
pubmed: 30061879
Nat Biotechnol. 2020 Dec;38(12):1408-1414
pubmed: 32747759
Cancer Med. 2017 Jan;6(1):298-309
pubmed: 28035765
Clin Exp Immunol. 2019 Jul;197(1):14-23
pubmed: 30076771
Annu Rev Immunol. 2001;19:475-96
pubmed: 11244044
J Immunol. 2020 Feb 15;204(4):733-744
pubmed: 32015076
Annu Rev Immunol. 2018 Apr 26;36:43-71
pubmed: 29144838
Int Immunol. 2006 Feb;18(2):269-77
pubmed: 16361311
Cell Rep. 2019 Oct 15;29(3):724-735.e4
pubmed: 31618639
Blood. 2017 Nov 23;130(21):2326-2338
pubmed: 28978570
Nat Methods. 2017 Oct;14(10):979-982
pubmed: 28825705
Nat Immunol. 2003 Apr;4(4):330-6
pubmed: 12612578
Nat Rev Cancer. 2007 Apr;7(4):270-80
pubmed: 17384582
Nat Commun. 2017 May 10;8:15244
pubmed: 28489076
Blood. 2011 Aug 18;118(7):1865-76
pubmed: 21705495
Wellcome Open Res. 2017 Sep 22;2:87
pubmed: 29062917
J Exp Med. 1985 Dec 1;162(6):2169-74
pubmed: 2866223
Br J Haematol. 2004 Jul;126(1):81-4
pubmed: 15198736
Leuk Lymphoma. 2015 Jun;56(6):1806-12
pubmed: 25219595
Nat Commun. 2020 Apr 14;11(1):1801
pubmed: 32286271
Nat Commun. 2021 Aug 10;12(1):4821
pubmed: 34376672
J Immunol. 2006 Apr 15;176(8):4622-31
pubmed: 16585553
Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415-9
pubmed: 6261256
Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):E1269-E1278
pubmed: 29358408
Blood. 2003 Apr 1;101(7):2704-10
pubmed: 12433692
Cancer Cell. 2012 Jan 17;21(1):121-35
pubmed: 22264793
J Immunol. 2006 Oct 15;177(8):5718-26
pubmed: 17015761
Nat Genet. 2015 Nov;47(11):1304-15
pubmed: 26437031
Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):720-5
pubmed: 16407133
Sci Immunol. 2019 May 31;4(35):
pubmed: 31152091
J Biol Chem. 2003 Oct 31;278(44):43620-7
pubmed: 12937177
Int Immunol. 1995 Aug;7(8):1295-9
pubmed: 7495736
Nat Biotechnol. 2021 Aug;39(8):958-967
pubmed: 33649568
Nat Immunol. 2011 Aug 14;12(9):898-907
pubmed: 21841785
J Immunol. 1981 Apr;126(4):1393-7
pubmed: 6970774
Biochim Biophys Acta. 2016 Jun;1863(6 Pt A):1269-81
pubmed: 27033518
Immunity. 2009 Jun 19;30(6):899-911
pubmed: 19464196

Auteurs

Benjy Jy Tan (BJ)

Division of Genomics and Transcriptomics, Joint Research Center for Human Retrovirus Infection.
International Research Center for Medical Sciences (IRCMS), and.
Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Kenji Sugata (K)

Division of Genomics and Transcriptomics, Joint Research Center for Human Retrovirus Infection.

Omnia Reda (O)

Division of Genomics and Transcriptomics, Joint Research Center for Human Retrovirus Infection.
International Research Center for Medical Sciences (IRCMS), and.
Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Department of Microbiology, High Institute of Public Health, Alexandria University, Alexandria, Egypt.

Misaki Matsuo (M)

Division of Genomics and Transcriptomics, Joint Research Center for Human Retrovirus Infection.
International Research Center for Medical Sciences (IRCMS), and.

Kyosuke Uchiyama (K)

School of Medicine, Kumamoto University, Kumamoto, Japan.

Paola Miyazato (P)

International Research Center for Medical Sciences (IRCMS), and.

Vincent Hahaut (V)

Institute of Molecular and Clinical Ophthalmology Basel, Basel, Switzerland.
Department of Ophthalmology, University of Basel, Basel, Switzerland.

Makoto Yamagishi (M)

Laboratory of Tumor Cell Biology, Department of Computational Biology and Medical Sciences and.

Kaoru Uchimaru (K)

Laboratory of Tumor Cell Biology, Department of Computational Biology and Medical Sciences and.

Yutaka Suzuki (Y)

Laboratory of Systems Genomics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.

Takamasa Ueno (T)

Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.

Hitoshi Suzushima (H)

Department of Hematology, Kumamoto Shinto General Hospital, Kumamoto, Japan.

Hiroo Katsuya (H)

International Research Center for Medical Sciences (IRCMS), and.
Division of Hematology, Respiratory Medicine and Oncology, Saga University, Saga, Japan.

Masahito Tokunaga (M)

Department of Hematology, Imamura General Hospital, Kagoshima, Japan.

Yoshikazu Uchiyama (Y)

Division of Informative Clinical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

Hideaki Nakamura (H)

Department of Transfusion Medicine and.

Eisaburo Sueoka (E)

Department of Clinical Laboratory Medicine, Faculty of Medicine, Saga University, Saga, Japan.

Atae Utsunomiya (A)

Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.

Masahiro Ono (M)

International Research Center for Medical Sciences (IRCMS), and.
Department of Life Sciences, Imperial College London, London, United Kingdom.

Yorifumi Satou (Y)

Division of Genomics and Transcriptomics, Joint Research Center for Human Retrovirus Infection.
International Research Center for Medical Sciences (IRCMS), and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH